# BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal Arteries

> **NCT01867736** · NA · COMPLETED · sponsor: **Biotronik AG** · enrollment: 72 (actual)

## Conditions studied

- Atherosclerosis
- Arteriosclerosis
- Vascular Disease
- Peripheral Artery Disease

## Interventions

- **DEVICE:** Passeo-18 Lux DRB
- **DEVICE:** Standard PTA (POBA)

## Key facts

- **NCT ID:** NCT01867736
- **Lead sponsor:** Biotronik AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2014-01
- **Final completion:** 2014-07
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2015-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01867736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01867736, "BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal Arteries". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01867736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*